Disease · fungal

Blueberry leaf spot

Ophiodothella vaccinii

Description

Ophiodothella vaccinii is a fungal pathogen responsible for causing leaf spot disease in blueberry plants. It specifically targets various Vaccinium species, negatively impacting the foliage and overall vigor of both wild and cultivated blueberry varieties in regions with favorable climate conditions.

The primary symptoms of this disease include the formation of distinct lesions on the leaves. Initially, these appear as small, chlorotic or light-colored spots. As the fungus progresses, these spots expand, darken to a brown or necrotic black color, and are often surrounded by a characteristic red or purple halo, which is a key diagnostic feature for field identification.

Environmental conditions play a critical role in the prevalence and spread of the pathogen. The fungus thrives in moist, cool to temperate environments, particularly where foliage remains wet for extended periods due to rain, irrigation, or heavy morning dew. Conidia and ascospores, produced within the lesions, are dispersed by wind and splashing water to facilitate secondary infection cycles.

The impact of this disease on blueberry production can be significant. By inducing premature defoliation, the fungus severely disrupts photosynthesis, leading to reduced plant health and diminished berry yield. Furthermore, the loss of leaves late in the season reduces the plant's ability to store energy, making it more susceptible to frost damage and winter kill.

Management strategies focus on reducing inoculum pressure and optimizing plant vigor. Key practices include:

  • removing and destroying infected plant debris;
  • improving air circulation within the canopy through proper pruning;
  • applying registered fungicides during the early stages of disease development to inhibit spore germination and colonization.
Integrated pest management remains the most sustainable approach to mitigating the threat posed by this pathogen.

Marketplace

Products · 0

Community

Discussion

No discussions yet — be the first.